申请人:Dudley Danette
公开号:US20110269696A1
公开(公告)日:2011-11-03
The invention provides novel compounds that are inhibitors of IAPs having the general formula: wherein X
1
, X
2
, X
3
, Y, A, R
1
, R
2
, R
3
, R
4
, R
4′
, R
5
, R
5′
, R
6
and R
6′
are as described herein. The compouds of the invention may be used to induce apoptosis in cells (or sensitise cells to apoptosis) in which IAPs are overexpressed or otherwise implicated in resistance to normal apoptotic processes. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment cancers.
该发明提供了一种通式为以下的IAPs抑制剂新化合物:其中X1、X2、X3、Y、A、R1、R2、R3、R4、R4′、R5、R5′、R6和R6′如本文所述。该发明的化合物可用于在IAPs过度表达或以其他方式涉及对正常凋亡过程的抵抗的细胞中诱导凋亡(或使细胞对凋亡敏感)。因此,这些化合物可以与药物适用的组成物一起提供,并用于治疗癌症。